Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on the Effectiveness and Safety of JNJ-77242113 and Deucravacitinib for Adults with Moderate to Severe Plaque Psoriasis

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    Germany Hungary Italy Poland Romania Spain
  • Study of early versus late risankizumab treatment to evaluate immune cell response in patients with moderate to severe psoriasis

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    Spain
  • Study to measure bimekizumab concentration in breast milk of breastfeeding mothers with psoriasis, psoriatic arthritis, axial spondyloarthritis, or hidradenitis suppurativa

    Not yet recruiting

    1 1 1 1
    Investigated Drugs:
    Germany Spain
  • Study on the Effectiveness of JNJ-77242113 and Deucravacitinib for Treating Moderate to Severe Plaque Psoriasis in Adults

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    France Germany Hungary Italy Poland Spain
  • ORKA-001 in Patients with Moderate-to-Severe Plaque Psoriasis

    Not recruiting

    2 1
    Investigated Diseases:
    Germany Spain
  • Study on the Effectiveness and Safety of ESK-001 and Apremilast for Adults with Moderate to Severe Plaque Psoriasis

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Bulgaria Czechia Germany Poland Portugal
  • A study to examine how the body processes and removes DC-806 in healthy male volunteers

    Not recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands
  • Testing IDOR-1117-2520 for Adults with Moderate to Severe Chronic Plaque Psoriasis With or Without Psoriatic Arthritis

    Not recruiting

    2 1
    Investigated Drugs:
    Bulgaria Romania
  • Comparison of zasocitinib and deucravacitinib in adults with moderate to severe plaque psoriasis

    Not recruiting

    3 1 1
    Investigated Diseases:
    Bulgaria Czechia France Latvia Poland
  • Study of zasocitinib (TAK-279) and apremilast compared to placebo in adults with moderate to severe plaque psoriasis

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Czechia France Germany Greece Hungary +3